Long-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)
Condition: Hemophilia B Intervention: Genetic: AAV5-hFIXco-Padua Sponsor: CSL Behring Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials